A solid Q3 update confirms modest sales growth in Q3 (+2.3%), driven by another strong performance from the Consumer sectors and from Life Sciences in particular (+7.3%) on the back of the pharma grade Omega 3 API launch in the US. Q3 margins were ahead of the prior year with growth of New and Protected Products (NPP) well ahead of overall sales. Full year expectations are reiterated on a constant currency basis, implying a modest currency related downgrade to forecasts.
05 Nov 2015
Solid Q3 update, NPP growth benefiting margins
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Solid Q3 update, NPP growth benefiting margins
Croda International Plc (CRDA:LON) | 4,884 1318.8 0.6% | Mkt Cap: 6,820m
- Published:
05 Nov 2015 -
Author:
James Tetley -
Pages:
3
A solid Q3 update confirms modest sales growth in Q3 (+2.3%), driven by another strong performance from the Consumer sectors and from Life Sciences in particular (+7.3%) on the back of the pharma grade Omega 3 API launch in the US. Q3 margins were ahead of the prior year with growth of New and Protected Products (NPP) well ahead of overall sales. Full year expectations are reiterated on a constant currency basis, implying a modest currency related downgrade to forecasts.